can cbt or a beta blocker help people overcome a fear of public speaking?
“people can use cognitive behavioral therapy or a beta blocker for that matter to successfully overcome that”
a host, a neuroscientist said on Huberman Lab, 2026-10-26, at 1:43:47. hear it in context →
first, the part that holds
the cbt half holds up: a 2019 meta-analysis of 30 randomized trials found psychological treatments, mostly cognitive-behavioral, reduced fear of public speaking by a moderate-to-large amount, and the gains grew after treatment ended. beta blockers have some support too: in a randomized trial, one 40 mg dose of propranolol before a videotaped speech lowered the anxiety observers could see in anxious speakers.
what we found when we went and looked
for cbt and related psychological treatments, a meta-analysis of 30 randomized trials (1,355 participants) found a pooled effect of g = 0.74 right after treatment and g = 1.11 at follow-up. that is close to what the speaker said. the beta-blocker half rests on something different. a single dose taken before a speech dampens visible anxiety on that day. but in randomized trials in diagnosed social phobia, atenolol did no better than placebo (30% vs 23% response), and exposure-based behavior therapy beat placebo where atenolol did not. a 2016 systematic review concluded the evidence was insufficient to support routine propranolol use for any anxiety disorder. putting the two side by side as equal ways to "overcome" the fear inflates what the beta-blocker evidence shows.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| cognitive behavioral therapy can successfully treat fear of public speaking | confirmed | a 2019 meta-analysis of 30 rcts (1,355 participants, 62 interventions, 50 of them cognitive-behavioral) found g = 0.74 (95% ci 0.61-0.87) after treatment, about 1 in 2.5 treated people helped. g = 0.65 against placebo or attention controls, and g = 1.11 at follow-up. limits: 26 of the 30 trials used subclinical samples, 29 of 30 analyzed only people who finished, and allocation concealment was unclear in 28. the authors say this may overestimate the effect. [1] |
| a beta blocker can successfully help people overcome public speaking phobia | overstated | there is short-term relief for a single performance: propranolol 40 mg before a videotaped speech reduced observer-rated anxiety and pulse in anxious volunteers, but it impaired their recall of difficult words. there is no evidence that it resolves the phobia. in diagnosed social phobia, 8 weeks of atenolol did not differ from placebo (30% vs 23% response, n = 74). in a second rct (n = 72), flooding beat placebo and atenolol did not. [3][4][5] |
| cbt and beta blockers are comparable options for overcoming the fear | overstated | the only head-to-head trial found here (behavior therapy vs atenolol vs placebo, n = 72) favored behavior therapy on behavioral measures and composite indexes, and its gains held at follow-up. atenolol did not separate from placebo. a 2016 systematic review of propranolol across anxiety disorders found one social phobia trial (n = 16) with no drug-placebo difference, and called the evidence insufficient for routine use. [2][5] |
both directions
for the speaker: the cbt evidence base is large and consistent: 30 rcts with low-to-moderate heterogeneity, effects that hold against active placebo controls, and benefits that keep growing after treatment ends. technology-delivered versions worked as well as face-to-face ones. for beta blockers, a randomized trial found a single dose of propranolol before a speech reduced the anxiety observers could see and lowered pulse in anxious speakers. that fits the common use of beta blockers for one-off performance situations. the 2016 propranolol review's introduction also cites earlier work in musicians and surgeons, though it did not formally evaluate those studies.
against: "overcome" implies the fear goes away, and beta blockers have not been shown to do that. in two randomized trials in diagnosed social phobia, 8 weeks of atenolol was no better than placebo, and exposure-based behavior therapy beat atenolol directly. the only social phobia trial in the 2016 propranolol review found no drug-placebo difference. that review concluded the evidence does not support routine propranolol use for any anxiety disorder. even the positive speech trial found a cognitive cost: anxious speakers on propranolol recalled difficult words worse. the beta-blocker evidence supports a short-acting symptom aid for one event, not a treatment that matches cbt.
what this cannot say
the beta-blocker trials are old (1981-1994) and small, and the negative ones enrolled mostly generalized social phobia: 76% in the phenelzine/atenolol trial. people whose fear is limited to performing may respond differently, and those trials cannot rule that out. no modern, adequately powered rct of propranolol for public speaking anxiety turned up in what we read. for the 1983 speech trial we read only the abstract, which gives no sample size. the cbt meta-analysis mostly enrolled subclinical, completer-only samples, so its effect sizes may run high. we did not search systematically: this check rests on two reviews and three trials found through targeted searches. we could not open the nice social anxiety guideline (the server returned an error), so it is not cited.
sources, each one fetched and read
- Psychological interventions for the fear of public speaking: a meta-analysis. Frontiers in Psychology, 2019;10:488. doi:10.3389/fpsyg.2019.00488. PMC6428748 What we read there: 30 rcts, 1,355 participants; pooled g = 0.74 (95% ci 0.61-0.87) after treatment, nnt 2.50; g = 0.65 vs placebo/attention control; g = 1.11 at follow-up; 26 of 30 studies subclinical samples; only one used intention-to-treat analysis, which 'may have led to an overestimation of effect sizes.' Fetched 2026-11-04 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC6428748/
- Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. Journal of Psychopharmacology, 2016;30(2):128-139. PMC4724794 What we read there: eight rcts; one social phobia study (n = 16) found 'no significant differences or trends between the drug and placebo on any outcome measures'; 'the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders.' Fetched 2026-11-04 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC4724794/
- Effect of beta adrenergic blocking drugs on speakers' performance and memory. British Journal of Psychiatry, 1983;142(5) What we read there: propranolol 40 mg vs placebo before a videotaped speech 'clearly reduced rated anxiety in the non-verbal behaviour of anxious subjects', lowered pulse, and impaired recall of difficult words in anxious subjects. Fetched 2026-11-04 (HTTP 200). https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/effect-of-beta-adrenergic-blocking-drugs-on-speakers-performance-and-memory/747EC9897B1362C6F89AA8CF4E212EB4
- Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry, 1992;49(4):290-300. doi:10.1001/archpsyc.49.4.290. PMID 1558463 What we read there: 74 patients, 8 weeks double-blind; response rates '64% for phenelzine, 30% for atenolol, and 23% for placebo'; no significant difference between atenolol and placebo; 76% of the sample had generalized social phobia. Fetched 2026-11-04 (HTTP 203). https://pubmed.ncbi.nlm.nih.gov/1558463/
- Social phobia: a comparison of behavior therapy and atenolol. Journal of Consulting and Clinical Psychology, 1994;62(2):350-358. PMID 8201073 What we read there: 72 participants randomized to flooding, atenolol or placebo; 'flooding consistently was superior to placebo, whereas atenolol was not'; behavior therapy also beat the drug on behavioral measures and composite indexes, and its gains held at follow-up. Fetched 2026-11-04 (HTTP 203). https://pubmed.ncbi.nlm.nih.gov/8201073/
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam